Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus.

Although drugs used in renal transplant recipients such as steroids, cyclosporine, and particularly, tacrolimus have diabetogenic potential, diabetic ketoacidosis is uncommon. There are few data concerning the long-term follow-up of these patients. Diabetic ketoacidosis occurred in a renal transplant recipient following de novo development associated with tacrolimus. Copyright 2004 Elsevier Inc.